V

VERALOX Therapeutics

18 employees

Veralox Therapeutics develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type one diabetes.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Therapeutics
Medical
Pharmaceutical

Date founded

2018

Funding rounds raised

Total raised

$24M

from 16 investors over 16 rounds

V

VERALOX Therapeutics raised $24M on June 20, 2023

Investors: Sanofi Ventures, JDRF T1D Fund, Genesys Capital, Pappas Capital and NYBC Ventures

V

VERALOX Therapeutics raised $17M on June 16, 2021

Investors: Sanofi Ventures, Point Field Partners, VTC Innovation Fund, JDRF T1D Fund, Genesys Capital, Maryland Momentum Fund and Alumni Ventures Group

V

VERALOX Therapeutics raised $5.4M on September 5, 2019

Investors: VTC Innovation Fund, Sanofi Ventures, JDRF T1D Fund and Maryland Momentum Fund

FAQ